However, it binds both diffuse and dense-core amyloid along with tau (Coimbra et al., 2006; Mistur et al., 2009; Rabinovici and Jagust, 2009), complicating its interpretation and limiting its ability to differentiate AD from FTD and other tauopathies. This evidence concerns the gene MAPT and Alzheimer disease.